Product Information
- Cgp 45715A
- (S-(R*,S*-(E,Z)))-7-((9-(4-Acetyl-3-hydroxy-2-propylphenoxy)-1-(hydroxy(3-(trifluoromethyl)phenyl)methyl)-2,4-nonadienyl)thio)-4-oxo-4H-1-benzopyran-2-carboxylic acid monosodium salt
- 1-Hydroxy-1-(3-trifluoromethylphenyl)-10-(4-acetyl-3-hydroxy-2-propylphenoxy)deca-3(E),5(Z)-diene-2-yl-7-thio-4-oxo-4H-1-benzopyran-2-carboxylic acid
- Cgp-45715 A
- 4H-1-Benzopyran-2-carboxylic acid, 7-((9-(4-acetyl-3-hydroxy-2-propylphenoxy)-1-(hydroxy(3-(trifluoromethyl)phenyl)methyl)-2,4-nonadienyl)thio)-4-oxo-, monosodium salt, (S-(R*,S*-(E,Z)))-
- sodium 7-{[(1S,2E,4Z)-9-(4-acetyl-3-hydroxy-2-propylphenoxy)-1-{(R)-hydroxy[3-(trifluoromethyl)phenyl]methyl}nona-2,4-dien-1-yl]sulfanyl}-4-oxo-4H-chromene-2-carboxylate
Iralukast Na is a leukotriene receptor antagonist that prevents bronchoconstrictor response. It binds to the cystic fibrosis transmembrane conductance regulator (CFTR) and blocks the binding of leukotrienes, which are potent bronchoconstrictors. Iralukast Na also blocks the activity of inflammatory cells and reduces bowel inflammation. Iralukast Na has been shown to be effective in treating asthma, inflammatory bowel disease, and other autoimmune diseases.
Chemical properties
Technical inquiry about: 3D-FS104155 Iralukast Na
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.